GB Sciences, Inc.
GBLX
$0.0002
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -71.39% | -4.15% | 175.57% | -42.55% | 99.96% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -71.39% | -4.15% | -30.15% | -42.55% | 99.96% |
| Operating Income | 71.39% | 4.15% | 30.15% | 42.55% | -99.96% |
| Income Before Tax | 56.13% | -4.36% | 83.70% | 58.27% | -38.68% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 56.13% | -4.36% | 83.70% | 58.27% | -38.68% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 56.13% | -4.36% | 83.70% | 58.27% | -38.68% |
| EBIT | 71.39% | 4.15% | 30.15% | 42.55% | -99.96% |
| EBITDA | 71.42% | 3.97% | 30.15% | 39.39% | -115.94% |
| EPS Basic | 72.22% | 0.00% | 84.00% | 58.33% | -100.00% |
| Normalized Basic EPS | 66.67% | 0.00% | -50.00% | 57.14% | -50.00% |
| EPS Diluted | 72.22% | 0.00% | 84.00% | 58.33% | -100.00% |
| Normalized Diluted EPS | 66.67% | 0.00% | -50.00% | 57.14% | -50.00% |
| Average Basic Shares Outstanding | 2.86% | 6.47% | 6.93% | 6.40% | 14.29% |
| Average Diluted Shares Outstanding | 2.86% | 6.47% | 6.93% | 6.40% | 14.29% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |